Back to search results

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

Abroad (travel likely)RecruitingPHASE3

Conditions

Acne Scars

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Advanced Research Associates - Glendale /ID# 254961, Glendale, Arizona, United States

  • Marcus Facial Plastic Surgery /ID# 275880, Redondo Beach, California, United States

  • Pacific Clinical Innovations /ID# 256185, Vista, California, United States

  • DMR Research PLLC /ID# 256199, Westport, Connecticut, United States

  • Hamilton Research, LLC /ID# 256925, Alpharetta, Georgia, United States

  • Aesthetic Center at Woodholme /ID# 256197, Baltimore, Maryland, United States

  • The Center for Dermatology Cosmetics & Laser Surgery /ID# 256182, Mount Kisco, New York, United States

  • Wilmington Dermatology Center /ID# 256192, Wilmington, North Carolina, United States

  • Austin Institute for Clinical Research - Pflugerville /ID# 256200, Pflugerville, Texas, United States

  • SkinDC /ID# 254962, Arlington, Virginia, United States

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)